Vident Investment Advisory, LLC Invitae Corp Transaction History

Vident Investment Advisory, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$1.05 - $1.63 $59,913 - $93,007	-57,060 Reduced 79.5%	14,714 $16,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $12,082 - $27,488	10,069 Added 16.32%	71,774 $96,000
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $30,521 - $64,434	17,849 Added 40.7%	61,705 $114,000
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $16,991 - $77,178	8,943 Added 25.62%	43,856 $94,000
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $74,364 - $314,566	34,913 New	34,913 $84,000

Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $69,594 - $172,768	-11,082 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $162,905 - $317,720	11,082 New	11,082 $169,000
Q3 2021 Nov 12, 2021	SELL	$24.31 - $33.6 $151,815 - $209,832	-6,245 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$26.09 - $40.4 $162,932 - $252,298	6,245 New	6,245 $211,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.